Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
AOD-9604 Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse AOD-9604 doses across species and administration routes: Rodent studies: 250-500 mcg/kg orally or intraperitoneally was most common for obesity research Rabbit models: 0.25 mg per joint for osteoarthritis studies (intra-articular injection) Pig pharmacokinetic studies: 1.5 mg/kg IV and 2 mg/kg oral for metabolism characterization Human clinical trials: Oral doses of 0.25-10 mg daily
Gastrointestinal Disorders: Conditions like Crohn's disease, celiac disease, or a history of weight-loss surgery (like gastric bypass) can damage the exact parts of the intestine that are in charge of B12 absorption
B12 injections not only contain the much-needed B12 but also a formulation of lipotropics which are compounds that help break down and metabolize fat
NAD+ is essential for the electron transport chain in mitochondria, where the majority of cellular ATP is produced
